0H9X Stock Overview
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 1/6 |
| Financial Health | 4/6 |
| Dividends | 5/6 |
Fresenius Medical Care AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €36.33 |
| 52 Week High | €49.62 |
| 52 Week Low | €30.17 |
| Beta | 0.93 |
| 1 Month Change | 1.38% |
| 3 Month Change | 2.21% |
| 1 Year Change | -12.43% |
| 3 Year Change | -44.33% |
| 5 Year Change | -50.17% |
| Change since IPO | 10.21% |
Recent News & Updates
Recent updates
Shareholder Returns
| 0H9X | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | 1.6% | 1.3% | -0.7% |
| 1Y | -12.4% | -28.0% | -1.8% |
Return vs Industry: 0H9X exceeded the UK Healthcare industry which returned -28% over the past year.
Return vs Market: 0H9X underperformed the UK Market which returned -1.8% over the past year.
Price Volatility
| 0H9X volatility | |
|---|---|
| 0H9X Average Weekly Movement | 4.9% |
| Healthcare Industry Average Movement | 7.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: 0H9X has not had significant price volatility in the past 3 months.
Volatility Over Time: 0H9X's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 119,845 | Helen Giza | www.freseniusmedicalcare.com |
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient’s residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products.
Fresenius Medical Care AG Fundamentals Summary
| 0H9X fundamental statistics | |
|---|---|
| Market cap | €10.69b |
| Earnings (TTM) | €499.00m |
| Revenue (TTM) | €19.45b |
21.4x
P/E Ratio0.5x
P/S RatioIs 0H9X overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 0H9X income statement (TTM) | |
|---|---|
| Revenue | €19.45b |
| Cost of Revenue | €14.53b |
| Gross Profit | €4.93b |
| Other Expenses | €4.43b |
| Earnings | €499.00m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 07, 2024
| Earnings per share (EPS) | 1.70 |
| Gross Margin | 25.32% |
| Net Profit Margin | 2.57% |
| Debt/Equity Ratio | 53.3% |
How did 0H9X perform over the long term?
See historical performance and comparisonDividends
3.3%
Current Dividend Yield70%
Payout RatioDoes 0H9X pay a reliable dividends?
See 0H9X dividend history and benchmarks| Fresenius Medical Care dividend dates | |
|---|---|
| Ex Dividend Date | May 17 2024 |
| Dividend Pay Date | May 22 2024 |
| Days until Ex dividend | 27 days |
| Days until Dividend pay date | 32 days |
Does 0H9X pay a reliable dividends?
See 0H9X dividend history and benchmarks